Investment in production facilities
First written in FY2016-Q3. 19 of 34 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2021: 10 of 67 companies on the "Worse" side.
51 other companies' latest entry also says "Other".
- FY2026-H1Lower Capital ExpenditureAnnual report
「Cash generated from investing activities increased by ¥1,063 million (compared with a decrease of ¥1,769 million in the same period of the previous year). This was mainly attributable to ¥1,415 million in proceeds from the sale of property, plant and equipment.」
Cash outlays for the acquisition of property, plant and equipment decreased from ¥1,559 million in the same period of the previous year to ¥251 million, while the company recorded ¥1,415 million in proceeds from the sale of fixed assets. - FY2025AdvancedAnnual report
「Total capital expenditures for the consolidated fiscal year were ¥2,555 million, as detailed by segment below.」
The company continued capital expenditures aimed at expanding production facilities and enhancing and strengthening its research and development capabilities, and full-year capital expenditures increased from ¥1,036 million in the previous fiscal year to ¥2,555 million. The company acquired land and carried out vehicle and software upgrades and manufacturing equipment renewals. - FY2025-H1AdvancedAnnual report
「Cash used in investing activities decreased by ¥1,769 million (compared with an increase of ¥2,156 million in the same period of the previous year). This was mainly attributable to ¥1,559 million in cash outlays for the acquisition of property, plant and equipment.」
The company recorded ¥1,559 million in cash outlays for the acquisition of property, plant and equipment, and capital expenditures increased from ¥360 million in the same period of the previous year. - FY2024AdvancedAnnual report
「Total capital expenditures for the consolidated fiscal year were ¥1,036 million,」
The company continued capital expenditures aimed at expanding production facilities and enhancing and strengthening its research and development capabilities, and full-year capital expenditures increased from ¥974 million in the previous fiscal year to ¥1,036 million. - FY2024-Q2RestatedAnnual report
「This was mainly attributable to ¥360 million in cash outlays for the acquisition of property, plant and equipment.」
The company recorded ¥360 million in cash outlays for the acquisition of property, plant and equipment and continues to invest in production facilities and other assets. - FY2024-Q1RestatedAnnual report
「Net cash used in investing activities was ¥292 million, a year-on-year decrease of ¥26 million in expenditures. This was mainly due to ¥289 million in expenditures for the acquisition of property, plant and equipment.」
The company recorded cash outlays for the acquisition of property, plant and equipment and continues to invest in production facilities and other assets. - FY2023AdvancedAnnual report
「Total capital investment for the consolidated fiscal year was ¥974 million. Capital investment by segment is as follows.」
Capital investment increased from ¥605 million in the previous fiscal year to ¥974 million. The Cosmetics segment invested in software, the Pharmaceuticals and Food segment in manufacturing equipment, and the Other segment in replacement transport equipment. - FY2023-Q3RestatedAnnual report
「Net cash used in investing activities was ¥844 million, a year-on-year increase of ¥472 million in expenditures. This was mainly due to ¥537 million in expenditures for the acquisition of property, plant and equipment and ¥315 million in expenditures for the acquisition of intangible assets.」
Expenditures for the acquisition of property, plant and equipment and intangible assets were recorded, and investment in production facilities and other assets is continuing. - FY2023-Q2RestatedAnnual report
「Net cash used in investing activities was ¥532 million, a year-on-year increase of ¥170 million in expenditures. This was mainly due to ¥352 million in expenditures for the acquisition of property, plant and equipment and ¥179 million in expenditures for the acquisition of intangible assets.」
Expenditures for the acquisition of property, plant and equipment and intangible assets were recorded, and investment in production facilities and other assets is continuing. - FY2023-Q1RestatedAnnual report
「Net cash used in investing activities was ¥318 million, a year-on-year increase of ¥30 million in expenditures. This was mainly due to ¥164 million in expenditures for the acquisition of intangible assets and ¥154 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures for the acquisition of intangible assets and property, plant and equipment were recorded, and investment in production facilities and other assets is continuing. - FY2022AdvancedAnnual report
「Total capital investment for the consolidated fiscal year was ¥605 million.」
Capital investment continued for the purpose of expanding production facilities and enhancing and strengthening research and development functions, with full-year investment increasing from ¥539 million in the previous fiscal year to ¥605 million. - FY2022-Q3RestatedAnnual report
「Net cash used in investing activities was ¥372 million, a year-on-year increase of ¥38 million in expenditures. This was mainly due to ¥512 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures of ¥512 million for the acquisition of property, plant and equipment were recorded, and investment in production facilities and other assets is continuing. - FY2022-Q2RestatedAnnual report
「Net cash used in investing activities was ¥362 million, a year-on-year increase of ¥11 million in expenditures. This was mainly due to ¥334 million in expenditures for the acquisition of property, plant and equipment.」
Capital investment in the acquisition of property, plant and equipment is continuing. - FY2022-Q1AdvancedAnnual report
「Net cash used in investing activities was ¥288 million, a year-on-year increase of ¥195 million in expenditures. This was mainly due to ¥266 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures of ¥266 million for the acquisition of property, plant and equipment were recorded, and capital investment increased from ¥92 million in the same period of the previous year. - FY2021Capital investment continues; sharp decline in investmentAnnual report
「Total capital investment for the consolidated fiscal year was ¥539 million. Capital investment by segment is as follows.」
Capital investment aimed at expanding production facilities and enhancing research and development functions is continuing, but investment decreased from ¥1,456 million in the previous fiscal year to ¥539 million. - FY2021-Q3Continued Capital Investment; Lower Investment AmountAnnual report
「Net cash used in investing activities was ¥333 million, a year-on-year decrease of ¥801 million in expenditures. This was mainly due to ¥309 million in expenditures for the acquisition of property, plant and equipment.」
Capital investment in the acquisition of property, plant and equipment is continuing, but expenditures declined by ¥801 million year on year. - FY2021-Q2Capital investment continues; down year on yearAnnual report
「Net cash used in investing activities was ¥350 million, a year-on-year decrease of ¥752 million in expenditures. This was mainly due to ¥339 million in expenditures for the acquisition of property, plant and equipment.」
Capital investment is continuing, with ¥339 million in expenditures for the acquisition of property, plant and equipment, but expenditures declined by ¥752 million year on year. - FY2021-Q1Capital investment continues; quarterly investment declinesAnnual report
「Net cash used in investing activities was ¥93 million, a year-on-year decrease of ¥185 million in expenditures. This was mainly due to ¥92 million in expenditures for the acquisition of property, plant and equipment.」
Capital investment is continuing, with ¥92 million in expenditures for the acquisition of property, plant and equipment, but expenditures declined from ¥276 million in the same period of the previous year. - FY2020Continued Capital Investment; Lower Investment AmountAnnual report
「The Group continues to make capital investments aimed mainly at expanding production facilities and enhancing and strengthening research and development functions. Total capital investment for the consolidated fiscal year was ¥1,456 million.」
Investment in production facilities and research and development functions is continuing, but full-year investment decreased from ¥1,994 million in the previous fiscal year to ¥1,456 million. - FY2020-Q3RestatedAnnual report
「Net cash used in investing activities was ¥1,135 million, a year-on-year decrease of ¥745 million in expenditures. This was mainly due to ¥1,149 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures of ¥1,149 million for the acquisition of property, plant and equipment were recorded, and investment in production facilities and other assets is continuing. - FY2020-Q2RestatedAnnual report
「Net cash used in investing activities was ¥1,103 million, a year-on-year decrease of ¥99 million in expenditures. This was mainly due to ¥1,097 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures of ¥1,097 million for the acquisition of property, plant and equipment were recorded, and investment in production facilities and other assets is continuing. - FY2020-Q1RestatedAnnual report
「Net cash used in investing activities was ¥278 million, a year-on-year decrease of ¥552 million in expenditures. This was mainly due to ¥276 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures of ¥276 million for the acquisition of property, plant and equipment were recorded, and investment in production facilities and other assets is continuing. - FY2019AdvancedAnnual report
「Total capital investment for the consolidated fiscal year was ¥1,994 million. Capital investment by segment is as follows.」
Capital investment continued for the purpose of expanding production facilities and enhancing and strengthening research and development functions, with full-year investment increasing from ¥1,375 million in the previous fiscal year to ¥1,994 million. - FY2019-Q3RestatedAnnual report
「Net cash used in investing activities was ¥1,880 million, an increase of ¥991 million in expenditures year on year. This was mainly due to ¥1,607 million in expenditures for the acquisition of property, plant and equipment.」
Expenditures of ¥1,607 million for the acquisition of property, plant and equipment were recorded, and investment in production facilities and other assets is continuing. - FY2019-Q2RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥1,206 million」
Expenditures of ¥1,206 million for the acquisition of property, plant and equipment were also recorded during the cumulative second quarter of the consolidated fiscal year, and capital investment is continuing. - FY2019-Q1RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥833 million」
Expenditures of ¥833 million for the acquisition of property, plant and equipment were also recorded during the cumulative first quarter of the consolidated fiscal year, and capital investment is continuing. - FY2018RestatedAnnual report
「The Group continues to make capital investments aimed mainly at expanding production facilities and enhancing and strengthening research and development functions. Total capital investment for the consolidated fiscal year was ¥1,375 million.」
The policy of continuing capital investment to expand production facilities and strengthen research and development functions has been reaffirmed, together with full-year investment of ¥1,375 million. - FY2018-Q3RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥1,009 million」
Expenditures of ¥1,009 million for the acquisition of property, plant and equipment were also recorded during the cumulative third quarter of the consolidated fiscal year, and capital investment is continuing. - FY2018-Q2RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥774 million」
Expenditures of ¥774 million for the acquisition of property, plant and equipment were also recorded during the cumulative second quarter of the consolidated fiscal year, and capital investment is continuing. - FY2018-Q1RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥311 million」
Expenditures of ¥311 million for the acquisition of property, plant and equipment were also recorded in the first quarter, and capital investment is continuing. - FY2017AdvancedAnnual report
「Total capital investment for the consolidated fiscal year was ¥1,497 million. Capital investment by segment is as follows.」
Capital investment continued for the purpose of expanding production facilities and enhancing research and development functions, bringing full-year investment to ¥1,497 million. - FY2017-Q3RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥1,315 million」
Expenditures of ¥1,315 million for the acquisition of property, plant and equipment were also recorded during the cumulative third quarter of the consolidated fiscal year, indicating that capital investment is continuing. - FY2017-Q2RestatedAnnual report
「Expenditures for the acquisition of property, plant and equipment: ¥274 million」
Expenditures of ¥274 million for the acquisition of property, plant and equipment were recorded during the cumulative second quarter of the consolidated fiscal year, indicating that capital investment is continuing. - FY2016-Q3First statedAnnual report
「This was mainly due to a ¥1,294 million increase in lease assets, net, resulting from investment in production facilities.」
Investment in production facilities was made during the cumulative third quarter of the consolidated fiscal year, increasing lease assets by ¥1,294 million.